Genomikai módszerek alkalmazása ismeretlen etiológiájú és emerging fertőző betegségek diagnosztikájában
hungarian
Henczkó Judit
Health Sciences
Dr. Nagy Zoltán Zsolt
Országos Népegészségügyi Intézet, „A” épület Kertai Pál terem
2026-11-30 09:00:00
Public health
Dr. Ács Nándor
Dr. Kis Zoltán
Dr. Kádár Béla
Dr. Jakab Szilvia
Dr. Ostorházi Eszter
Dr. Stercz Balázs
Dr. Gyuranecz Miklós
Genomic methods are playing an increasingly important role in the diagnosis of infectious diseases. The aim of this doctoral dissertation was to improve the diagnosis of infectious diseases caused by pathogens of unknown etiology, rare pathogens, and emerging pathogens through the application of clinical metagenomic next-generation sequencing (mNGS) and whole-genome sequencing (WGS).
The first part of the dissertation focused on the metagenomic analysis of respiratory and other clinical specimens. The non-targeted approach of mNGS enabled the simultaneous detection of a broad range of pathogens and facilitated the identification of the etiology of complex infectious cases. Numerous rare or unexpected pathogens were identified, demonstrating that clinical metagenomics represents a valuable complementary diagnostic tool in cases where conventional microbiological methods fail to establish the causative agent. Furthermore, the investigation of acute necrotizing encephalopathy confirmed the association between influenza A virus infection and immune-mediated pathogenesis.
The second part of the dissertation presents the genomic analysis of two melioidosis cases diagnosed in Hungary. WGS and cgMLST analyses demonstrated that the infections resulted from two independent travel-associated importation events.
The third part of the dissertation investigated the molecular epidemiology and genomic characteristics of 25 clinical non-O1, non-O139 Vibrio cholerae isolates identified in Hungary between 2018 and 2025. Our findings suggest that most infections were associated with domestic environmental exposure. Whole-genome sequencing revealed considerable genetic diversity together with alternative virulence- and antimicrobial resistance-associated genetic determinants. A major finding was the investigation of a primary non-O1/non-O139 Vibrio cholerae pneumonia case, providing the first genomic evidence in Europe of a direct link between clinical and environmental isolates.
Overall, the findings demonstrate that clinical metagenomics and whole-genome sequencing substantially contribute to the diagnosis of rare, emerging, and infectious diseases of unknown etiology, as well as to the molecular epidemiological investigation of pathogens of public health importance. The routine implementation of genomic methods is expected to further improve the diagnosis of infectious diseases, patient management, and public health preparedness.